Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global burden of metabolic disease: Data from 2000 to 2019
Nicholas Chew, Cheng Han Ng, Darren Jun Hao Tan, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 414-428.e3
Closed Access | Times Cited: 396

Showing 1-25 of 396 citing articles:

Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
Elina Cho, C. Ang, Jingxuan Quek, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2138-2148
Closed Access | Times Cited: 125
Global burden of metabolic diseases, 1990–2021
Huai Zhang, Xiaodong Zhou, Michael D. Shapiro, et al.
Metabolism (2024) Vol. 160, pp. 155999-155999
Closed Access | Times Cited: 75
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
Daniel Q. Huang, Nabil Noureddin, Veeral Ajmera, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 829-836
Open Access | Times Cited: 71
SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
Qin Sun, Xiaorui Xing, Huanyu Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115586-115586
Open Access | Times Cited: 45
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity
Ibrahim AlZaim, Laura de Rooij, Bilal N. Sheikh, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 12, pp. 691-707
Closed Access | Times Cited: 42
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Metabolism (2024) Vol. 158, pp. 155958-155958
Closed Access | Times Cited: 29
Curcumin Mitigates the High-Fat High-Sugar Diet-Induced Impairment of Spatial Memory, Hepatic Metabolism, and the Alteration of the Gut Microbiome in Alzheimer’s Disease-Induced (3xTg-AD) Mice
Gopal Lamichhane, Jing Liu, Su‐Jeong Lee, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 240-240
Open Access | Times Cited: 25
Effectiveness and safety of drugs for obesity
Kristina H. Lewis, Caroline E Sloan, Daniel H. Bessesen, et al.
BMJ (2024), pp. e072686-e072686
Open Access | Times Cited: 25
Prevention of cardiorenal complications in people with type 2 diabetes and obesity
Daniel J. Drucker
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 338-353
Open Access | Times Cited: 22
Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 21
Is ChatGPT an Effective Tool for Providing Dietary Advice?
Valentina Ponzo, Ilaria Goitre, Enrica Favaro, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 469-469
Open Access | Times Cited: 18
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 18
Chronic intermittent fasting impairs β cell maturation and function in adolescent mice
Leonardo Matta, Peter Weber, Süheda Erener, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115225-115225
Closed Access | Times Cited: 2
Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation?
Jinyang An, Dzgoeva Fu, Ximei Chen, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates
Armachius James, Ke Wang, Yousheng Wang
Nutrients (2023) Vol. 15, Iss. 13, pp. 3022-3022
Open Access | Times Cited: 39
Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis
Bryan C. Tan, Xin‐Hui Pan, Han Shi Jocelyn Chew, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 8, pp. 677-685
Closed Access | Times Cited: 38
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation
Alessandro Maloberti, Alessandro Mengozzi, Elisa Russo, et al.
High Blood Pressure & Cardiovascular Prevention (2023) Vol. 30, Iss. 5, pp. 411-425
Open Access | Times Cited: 37
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic
Guocheng Rao, Xi Peng, Xinqiong Li, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
Pojsakorn Danpanichkul, Vincent Chen, Nathorn Chaiyakunapruk, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 340-349
Closed Access | Times Cited: 16
Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis
Xiahao Ding, Yin Li, Lin Zhang, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4583-4593
Open Access | Times Cited: 14
Weight-adjusted waist index as a practical predictor for diabetes, cardiovascular disease, and non-accidental mortality risk
Sitong Liu, Jiazhou Yu, Lu Wang, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 11, pp. 2498-2510
Closed Access | Times Cited: 14
Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality
Na Li, Yaqi Li, Liufu Cui, et al.
Atherosclerosis (2024) Vol. 397, pp. 118585-118585
Closed Access | Times Cited: 14
Physical Activity and Weight Loss Among Adults With Type 2 Diabetes and Overweight or Obesity
Zihao Huang, Xiaodong Zhuang, Rihua Huang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e240219-e240219
Open Access | Times Cited: 13
Molecular insights of exercise therapy in disease prevention and treatment
David Walzik, Tiffany Y. Wences Chirino, Philipp Zimmer, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates
Hongchuan Jin, Hui Chen, Li Xie, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 7, pp. 1321-1336
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top